Search results

117 items matching your search terms.
Filter the results.
Item type

New items since

Sort by relevance · date (newest first) · alphabetically
NIAID grant launches Kashuba's plan for HIV-prevention trials
Development of an AIDS vaccine is struggling. Topical treatments aimed at stopping HIV have made little progress. Angela Kashuba, PharmD, believes that antiretroviral drugs are the best hope for halting the spread of AIDS, especially in the developing world.
Located in Vital Signs / Archives / Vital Signs - Jan. 4, 2010
Pioneering study shows drug can purge dormant HIV
Researchers from the University of North Carolina at Chapel Hill have published pioneering research showing that a drug used to treat certain types of lymphoma was able to dislodge hidden virus in patients receiving treatment for HIV.
Located in News / 2012 / July
Researchers Discuss Challenges, Successes of HIV Cure Research in Science
A better understanding of HIV latency is the key to eradicating the virus researchers at the University of North Carolina and partner institutions write in a perspective in the journal Science.
Located in News / 2016 / July
Breast milk kills HIV and blocks its oral transmission in humanized mouse
New research from the University of North Carolina School of Medicine demonstrates that breast milk in a humanized mouse model has a strong virus killing effect and protects against oral transmission of HIV.
Located in News / 2012 / June
Cohen appointed to PEPFAR Scientific Advisory Board
Myron Cohen, MD, director of the UNC Institute for Global Health & Infectious Diseases and chief of the Division of Infectious Diseases in the Department of Medicine, has been appointed to the new Scientific Advisory Board of the President’s Emergency Plan for AIDS Relief (PEPFAR).
Located in Vital Signs / 2011 / Jan. 13
UNC Awarded $3.5 Million to Study HIV Transmission Prevention Among Newly Infected
A team of researchers from the UNC Institute for Global Health & Infectious Diseases has received a $3.5 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to study HIV prevention methods among people with acute HIV infection (AHI).
Located in Vital Signs / Archives / Vital Signs - July 31, 2009
UNC receives NIH grant to develop and test new drugs to block HIV infection
Scientists at the University of North Carolina at Chapel Hill schools of medicine and pharmacy have been awarded a $3 million federal grant to develop and test a new generation of treatments aimed at preventing sexual transmission of HIV to uninfected individuals. This remains the most common cause of HIV infection worldwide.
Located in News / 2011 / July
UNC School of Medicine again ranked highly by U.S. News & World Report
The School ranked 2nd in Primary Care and 22nd in Research overall in the 2015 U.S. News & World Report Best Medical School Rankings. Family Medicine, Rural Medicine and AIDS were also listed as top ten specialties.
Located in News / 2014 / March
Video: Researchers issue HIV goal: drug-free remission
A group of leading academic and industry scientists, including UNC's Dr. David Margolis, has issued a challenge to researchers studying HIV/AIDS: to find a way to effectively purge latent HIV infection and eliminate the need for chronic, suppressive therapy to control the disease.
Located in Vital Signs / 2009 / March
Margolis collaboration featured in The New Yorker
UNC School of Medicine researcher David Margolis, MD, was one of the first researchers to resist the common view that HIV is an incurable infection
Located in News / 2014 / December